1.0MedCity INVEST PharmaTechhttps://events.medcitynews.com/invest-pharmatecheclementshttps://events.medcitynews.com/invest-pharmatech/author/eclements/Daniel J. Hilferty - MedCity INVEST PharmaTechrich600338<blockquote class="wp-embedded-content" data-secret="5Apg7XXzG4"><a href="https://events.medcitynews.com/invest-pharmatech/speakers/dan-hilferty-2/">Daniel J. Hilferty</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://events.medcitynews.com/invest-pharmatech/speakers/dan-hilferty-2/embed/#?secret=5Apg7XXzG4" width="600" height="338" title="“Daniel J. Hilferty” — MedCity INVEST PharmaTech" data-secret="5Apg7XXzG4" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://events.medcitynews.com/invest-pharmatech/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://events.medcitynews.com/uploads/sites/3/2016/03/Dan_Hilferty_headshot2.jpg200200Daniel J. Hilferty is president and chief executive officer of Independence Blue Cross, one of the nation’s leading health insurers. Mr. Hilferty’s vision is to lead the transformation of health care in America, seeking innovative technologies and new models of care that will increase the quality and lower the cost of care. He led the…